Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 52, pseudogene (RN7SL52P) is a pseudogene of the 7SL RNA, a noncoding RNA critical for the function of the signal recognition particle (SRP) involved in protein targeting to the endoplasmic reticulum[6][5][1]. Pseudogenes like RN7SL52P are nonfunctional genomic copies typically derived from active parental genes through duplication or retrotransposition, but they do not encode functional RNA or protein themselves[3][4]. RN7SL52P does not encode a receptor, enzyme, or any functional target and is not considered a therapeutic target, nor is there evidence linking it to disease, drug interactions, or mechanisms of action. The parent 7SL RNA is notable as the evolutionary origin of Alu elements and is essential for protein translocation, but the RN7SL52P pseudogene lacks a defined biological function or therapeutic relevance[5][3]. The entry is primarily of genomic interest and not of clinical or pharmacological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 52, pseudogene (RN7SL52P).